Scinovex
articleTop 1% cited

Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion

Annals of Neurology · 2004 · Vol. 55(4) · pp. 458–468
Michael BarnettJohn W. Prineas

Abstract

The study describes the clinical and pathological findings in 12 patients with relapsing and remitting multiple sclerosis, who died during or shortly after the onset of a relapse. Pathological changes not previously associated with the formation of new symptomatic lesions were observed in seven cases, namely, extensive oligodendrocyte apoptosis and microglial activation in myelinated tissue containing few or no lymphocytes or myelin phagocytes. No current laboratory model of multiple sclerosis, in particular, experimental allergic encephalomyelitis, is known with these features, which raises the possibility of some novel process underlying new lesion formation in multiple sclerosis.

Multiple Sclerosis Research StudiesCytokine Signaling Pathways and InteractionsPeripheral Neuropathies and DisordersMultiple sclerosisPathologicalLesionPathologyMedicineRelapsing remittingEncephalomyelitisMyelinOligodendrocyteNeuroscience

MeSH terms

AdolescentAdultBrainFemaleHumansMaleOligodendrogliaSpinal CordApoptosisMicrogliaMultiple Sclerosis, Relapsing-Remitting
Citations
1,179
FWCI
55.29
field-weighted impact
References
67
Percentile
100%
vs. same field & year
Citations per year
Cited by
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
British Journal of Pharmacology · 2011 · 1,476 citations
The cuprizone animal model: new insights into an old story
Acta Neuropathologica · 2009 · 483 citations
Multiple sclerosis: experimental models and reality
Acta Neuropathologica · 2016 · 503 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion · Scinovex